Corcept Therapeutics Inc (CORT)
55.96
-0.13
(-0.23%)
USD |
NASDAQ |
Nov 21, 16:00
55.96
0.00 (0.00%)
After-Hours: 17:06
Corcept Therapeutics Price to Book Value: 9.178 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 9.199 |
| November 19, 2024 | 8.906 |
| November 18, 2024 | 8.630 |
| November 15, 2024 | 8.501 |
| November 14, 2024 | 8.986 |
| November 13, 2024 | 9.258 |
| November 12, 2024 | 9.478 |
| November 11, 2024 | 9.686 |
| November 08, 2024 | 9.775 |
| November 07, 2024 | 8.906 |
| November 06, 2024 | 8.894 |
| November 05, 2024 | 8.552 |
| November 04, 2024 | 8.210 |
| November 01, 2024 | 7.810 |
| October 31, 2024 | 8.032 |
| October 30, 2024 | 7.690 |
| October 29, 2024 | 7.907 |
| October 28, 2024 | 7.928 |
| October 25, 2024 | 7.754 |
| October 24, 2024 | 7.748 |
| October 23, 2024 | 7.882 |
| October 22, 2024 | 8.018 |
| October 21, 2024 | 8.049 |
| October 18, 2024 | 8.154 |
| October 17, 2024 | 7.731 |
| Date | Value |
|---|---|
| October 16, 2024 | 7.747 |
| October 15, 2024 | 7.677 |
| October 14, 2024 | 7.424 |
| October 11, 2024 | 7.446 |
| October 10, 2024 | 7.416 |
| October 09, 2024 | 7.529 |
| October 08, 2024 | 7.503 |
| October 07, 2024 | 7.320 |
| October 04, 2024 | 7.446 |
| October 03, 2024 | 7.382 |
| October 02, 2024 | 7.516 |
| October 01, 2024 | 7.662 |
| September 30, 2024 | 7.585 |
| September 27, 2024 | 7.699 |
| September 26, 2024 | 7.585 |
| September 25, 2024 | 7.455 |
| September 24, 2024 | 7.711 |
| September 23, 2024 | 7.527 |
| September 20, 2024 | 7.404 |
| September 19, 2024 | 7.171 |
| September 18, 2024 | 7.408 |
| September 17, 2024 | 6.959 |
| September 16, 2024 | 6.742 |
| September 13, 2024 | 6.679 |
| September 12, 2024 | 6.258 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.078
Minimum
Apr 07 2020
9.775
Maximum
Nov 08 2024
5.294
Average
5.048
Median
Jan 18 2023
Price to Book Value Benchmarks
| Catalyst Pharmaceuticals Inc | 3.812 |
| Madrigal Pharmaceuticals Inc | 9.238 |
| ADMA Biologics Inc | 21.71 |
| Alnylam Pharmaceuticals Inc | 984.20 |
| Akebia Therapeutics Inc | -- |
Price to Book Value Related Metrics
| PE Ratio | 44.41 |
| PS Ratio | 9.920 |
| PEG Ratio | 0.7994 |
| Price to Free Cash Flow | 43.72 |
| Price | 55.96 |
| Earnings Yield | 2.25% |
| Market Cap | 5.863B |
| PEGY Ratio | 0.7994 |
| Operating PE Ratio | 43.49 |
| Normalized PE Ratio | 44.41 |